RANI

SEC source: 0001104659-23-060817 · tm2314845-3_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,866,389

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.89 to $4.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-060817 · tm2314845-3_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,863,744

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.78 to $3.99 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-058462 · tm2314845-2_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,861,134

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.26 to $4.62 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-056424 · tm2314845-1_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,856,714

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.83 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-054940 · tm2311848-9_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,854,674

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.645 to $4.80 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-050432 · tm2311848-8_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,852,501

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.39 to $4.60 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-050432 · tm2311848-8_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,848,078

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.66 to $4.705 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-049097 · tm2311848-7_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,843,798

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $5.15 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-049097 · tm2311848-7_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,839,698

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.32 to $5.38 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-047682 · tm2311848-6_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,837,848

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.37 to $5.40 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-046614 · tm2311848-5_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,835,998

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.20 to $5.29 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-045603 · tm2312872-1_4seq.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,834,097

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-045603 · tm2312872-1_4seq.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,833,207

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.405 to $5.59 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-044438 · tm2311848-4_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,829,630

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.57 to $5.66 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-044438 · tm2311848-4_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,827,865

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.065 to $5.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-043508 · tm2311848-3_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,825,942

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.12 to $5.24 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-042563 · tm2311848-2_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,818,391

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.42 to $5.50 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-042563 · tm2311848-2_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,811,111

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.43 to $5.50 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-041984 · tm2311848-1_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,806,695

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.12 to $5.35 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-040729 · tm238347d10_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,803,108

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.95 to $5.12 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-040729 · tm238347d10_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,802,357

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.99 to $5.58 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-039082 · tm238347-9_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,790,127

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.40 to $5.605 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001415889-23-005598 · form4-03302023_010306.xml · derivative · entry 2

Hashim Mir · CIK 0001875891 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,800

Underlying: Class A Common Stock · 205,800 shares

Expires 2033-03-26

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

SEC source: 0001415889-23-005598 · form4-03302023_010306.xml · nonDerivative · entry 1

Hashim Mir · CIK 0001875891 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,265

F1 · date: The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.

SEC source: 0001415889-23-005592 · form4-03302023_120352.xml · derivative · entry 2

Imran Talat · CIK 0001869579 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 575,600

Underlying: Class A Common Stock · 575,600 shares

Expires 2033-03-26

F3 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

SEC source: 0001415889-23-005592 · form4-03302023_120352.xml · nonDerivative · entry 1

Imran Talat · CIK 0001869579 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,445

F1 · date: The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.

F2 · balance_after: Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

SEC source: 0001415889-23-005596 · form4-03302023_010356.xml · derivative · entry 2

Sanford Svai S · CIK 0001591411 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,800

Underlying: Class A Common Stock · 205,800 shares

Expires 2033-03-26

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

SEC source: 0001415889-23-005596 · form4-03302023_010356.xml · nonDerivative · entry 1

Sanford Svai S · CIK 0001591411 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,597

F1 · date: The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.

SEC source: 0001415889-23-005600 · form4-03302023_010335.xml · derivative · entry 2

Groen Eric · CIK 0001918630 · GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,800

Underlying: Class A Common Stock · 205,800 shares

Expires 2033-03-26

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/4th of the shares subject to the option vest monthly over four years from March 27, 2023.

SEC source: 0001415889-23-005600 · form4-03302023_010335.xml · nonDerivative · entry 1

Groen Eric · CIK 0001918630 · GENERAL COUNSEL

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,216

F1 · date: The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.

SEC source: 0000899243-23-009584 · doc4.xml · nonDerivative · entry 1

Hashim Mir · CIK 0001875891 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,265

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Dr. Hashim on March 22, 2022.

SEC source: 0000899243-23-009585 · doc4.xml · nonDerivative · entry 1

Imran Talat · CIK 0001869579 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,945

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Imran on March 22, 2022.

F2 · balance_after: Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

SEC source: 0000899243-23-009587 · doc4.xml · nonDerivative · entry 1

Sanford Svai S · CIK 0001591411 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,597

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Sanford on March 22, 2022.

F2 · balance_after: Includes 2,214 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 1, 2022.

SEC source: 0000899243-23-009586 · doc4.xml · nonDerivative · entry 1

Groen Eric · CIK 0001918630 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,216

F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Groen on March 22, 2022.

F2 · balance_after: Includes 2,214 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 1, 2022.

SEC source: 0001104659-23-035492 · tm238347-8_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,786,617

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.00 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-035492 · tm238347-8_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,783,387

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.27 to $6.30 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-034345 · tm238347-7_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,782,855

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.10 to $6.20 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-034345 · tm238347-7_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,779,875

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.02 to $6.10 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-032652 · tm238347-6_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,778,550

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.06 to $6.15 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-031099 · tm238347-4_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,776,087

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.45 to $6.67 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-031099 · tm238347-4_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,772,357

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.505 to $6.60 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-029919 · tm238347-3_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,770,655

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.36 to $6.40 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-028960 · tm238347-2_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,769,555

F1 · price: These shares were purchased in a single transaction at a price of $6.31 per share.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-027777 · tm238347-1_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,765,655

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.29 to $6.30 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F2 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-026516 · tm237665-2_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,764,944

F2 · price: These shares were purchased in multiple transactions, each at $6.30 per share.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-026516 · tm237665-2_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,761,403

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.01 to $6.20 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-024727 · tm237665-1_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,755,952

F2 · price: These shares were purchased in multiple transactions, each at $6.10 per share.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-024727 · tm237665-1_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,754,952

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.85 to $6.00 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-023608 · tm237324-1_4seq1.xml · nonDerivative · entry 2

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,751,872

F2 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.72 to $6.00 per share, inclusive. The reporting persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.

SEC source: 0001104659-23-023608 · tm237324-1_4seq1.xml · nonDerivative · entry 1

South Cone Investments Limited Partnership · CIK 0001876412 · 10% owner

South Lake One LLC · CIK 0001794292 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares indirectly held through South Lake One LLC

Disclosed balance after: 6,743,404

F1 · price: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.21 to $5.62 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

F3 · ownership.nature: South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.